4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-010137
CEO acquired 13,850 shares (option exercise)
- CEO acquired 56,250 shares (grant or award)
- CEO acquired 225 shares (code L)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2023-03-06 | Other acquisition | +225 | 1,059,053 | D | ||
| Evans John M. CEO | 2023-03-31 | Grant or award | +56,250 | 1,115,303 | D | ||
| Evans John M. CEO | 2023-03-31 | Option exercise | +13,850 | $7.22 | $99,997 | 1,129,153 | D |
| Derivatives | |||||||
| Evans John M. CEO | 2023-01-31 | Grant or award · Stock Option (Right to Buy) | +112,500 | 112,500 | D | ||
| Evans John M. CEO | 2023-03-31 | Option exercise · Stock Option (Right to Buy) | −13,850 | 196,904 | D | ||
Loading xslF345X04/doc4.xml…